Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP17A1 | P05093 | 2/20 | 0.54 |
| ▸ | AR | P10275 | 6/20 | 0.52 |
| ▸ | PGR | P06401 | 5/20 | 0.52 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | SERPINA6 | P08185 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14200096 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL3750546 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL13139936 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL17302786 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL13397495 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL12437208 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL8843324 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL12101456 | 1.00 | CYP17A1 (0.54) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL11747587 | 0.89 | AR (0.48) | CYP17A1ARPGRNR3C2MAPT | |
| SCHEMBL24711581 | 0.86 | MAPT (0.49) | CYP17A1ARPGRNR3C2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118290508-A | Preparation method of dehydronandrolone acetate | 湖南新合新生物医药有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-118146286-A | Preparation method of dehydronandrolone acetate | 潘高峰 | 2024-06-07 | — | — | CN | claimed |
| CN-117736252-A | Fulvestrant key intermediate impurity and preparation method and application thereof | 杭州新博思生物医药有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-112094309-B | Preparation method of dehydronandrolone acetate key intermediate | 湖南新合新生物医药有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116284195-A | Preparation method of fulvestrant | 湖南欧亚药业有限公司 | 2023-06-23 | — | — | CN | claimed |
| CN-114634542-B | Preparation method of dehydronandrolone acetate | 湖北武当安泰药业有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-114634542-A | Preparation method of dehydronandrolone acetate | 湖北武当安泰药业有限公司 | 2022-06-17 | — | — | CN | claimed |
| CN-216295310-U | A filtrating collection device for production of dehydrogenation nandrolone acetate | 湖北三晶生物科技股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-118995644-B | 17 Beta-HSDcl enzyme mutant, carrier, microorganism and application thereof | 湖北大学 | 2025-11-04 | — | — | CN | disclosed |
| CN-120424152-A | Preparation method of dehydronandrolone acetate | 湖北共同甾体药物研究院有限公司 | 2025-08-05 | — | — | CN | disclosed |
| CN-120424152-A | Preparation method of dehydronandrolone acetate | 湖北共同甾体药物研究院有限公司 | 2025-08-05 | — | — | CN | disclosed |
| CN-116284195-B | Fulvestrant method for preparing group | 湖南欧亚药业有限公司 | 2025-07-01 | — | — | CN | disclosed |
| US-20250122236-A1 | INTERMEDIATE FOR PREPARING FULVESTRANT AND PREPARATION METHOD THEREFOR | SHANGHAI BEST-LINK BIOSCIENCE, LLC (CN) | 2025-04-17 | — | — | US | disclosed |
| CN-118995644-A | Cytochrome P450BM3 mutant, vector, microorganism and application thereof | 湖北大学 | 2024-11-22 | — | — | CN | disclosed |
| CN-113388589-B | Cytochrome P450 monooxygenase CYP109B2 mutant and application thereof | 湖北大学 | 2022-11-22 | — | — | CN | disclosed |
| CN-114634542-A | Preparation method of dehydronandrolone acetate | 湖北武当安泰药业有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-114634542-A | Preparation method of dehydronandrolone acetate | 湖北武当安泰药业有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-114634542-A | Preparation method of dehydronandrolone acetate | 湖北武当安泰药业有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-112094308-B | Preparation method of fulvestrant intermediate | 湖南新合新生物医药有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-216295310-U | A filtrating collection device for production of dehydrogenation nandrolone acetate | 湖北三晶生物科技股份有限公司 | 2022-04-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250122236-A1 | INTERMEDIATE FOR PREPARING FULVESTRANT AND PREPARATION METHOD THEREFOR | CYP19A1, HSD17B11, CYP17A1 | CYP17A1 3/4885AR 24/4885PGR 10/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.